Loneliness Clinical Trials
2 recruiting trials for Loneliness. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Loneliness clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Joint Authority for Päijät-Häme Social and Health Care (1), University of Zurich (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Therapies in nature (behavioral, 1 trial), followed by Social Support Just-in-Time Adaptive Intervention.
Track Loneliness trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Stroke Rehabilitation Utilizing Therapeutical Methods Designed for Nature Environments
Outpatient participants with a recent stroke diagnoses receive complimentary rehabilitation. The nature interventions include ergo- and physiotherapeutic and neurocognitive tasks...
Activating Social Resources in Psychotherapy-Seeking Individuals: Effectiveness and Timing of a Social Support...
This study evaluates a Just-In-Time Adaptive Intervention (JITAI) aiming to foster social support processes for adults with elevated depressive symptoms awaiting outpatient...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Loneliness, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Loneliness, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Loneliness, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.